Article

Higher-order aberrations increased by decentration of IOL

Decentration of an IOL increases higher-order aberrations, especially coma.

Dr. Baumeister, Dr. Kasper, and Prof. Kohnen carried out an intra-individual comparison of conventional spheric and aspheric (prolate surface-modified) foldable IOLs to determine the effect of decentration on higher-order aberrations.

The AR40e IOL (Advanced Medical Optics Inc., Santa Ana, CA) was implanted in one eye and the Tecnis Z9000 aspheric IOL (AMO) was implanted in the fellow eye.

Three months after the IOLs were implanted following phacoemulsification, optic decentration was measured using Scheimpflug photography (EAS-1000, Nidek, Fremont, CA), and the wavefront aberrations were measured using a Hartmann-Shack sensor (Zywave, Bausch & Lomb, Rochester, NY), he explained. Dr. Baumeister is lecturer in ophthalmology, Department of Ophthalmology, Johann Wolfgang Goethe- University, Frankfurt am Main, Germany.

"Clinically, there was excellent centration of the IOLs in our patients with no significant intra-individual differences. We found that the higher-order root mean square (RMS) values seemed to be more strongly correlated with the decentration in the wavefront-modified aspheric IOL, but this may be due to just one IOL that was decentered by more than 1 mm. Most of the IOLs were decentered by less than 0.5 mm.

"Therefore, the effect of decentration on higher-order RMS values, which should mainly be attributed to coma, may be stronger in wavefront-modified IOLs than in spheric IOLs if a significant decentration is present. Clinically, however, this had no effect on the visual outcome," Dr. Baumeister reported.

He cautioned that a larger study is needed to support this conclusion.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.